Price T Rowe Associates Inc Medpace Holdings, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 256,100 shares of MEDP stock, worth $105 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

256,100

Previous 252,878 1.27%

Holding current value

$105 Million

Previous $77.5 Million 33.53%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $917,851 - $1.33 Million	3,222 Added 1.27%	256,100 $104 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $3.1 Million - $4.26 Million	-13,619 Reduced 5.11%	252,878 $77.5 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $13.7 Million - $16.5 Million	-58,619 Reduced 18.03%	266,497 $64.5 Million
Q2 2023 Aug 14, 2023	SELL	$187.26 - $240.17 $354,857 - $455,122	-1,895 Reduced 0.58%	325,116 $78.1 Million
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $2.56 Million - $3.52 Million	-14,710 Reduced 4.3%	327,011 $61.5 Million

Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $2.62 Million - $3.88 Million	-17,146 Reduced 4.78%	341,721 $72.6 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $4.46 Million - $5.61 Million	-30,722 Reduced 7.89%	358,867 $56.4 Million
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $11.5 Million - $14.8 Million	-88,337 Reduced 18.48%	389,589 $58.3 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $2.13 Million - $3.29 Million	-15,330 Reduced 3.11%	477,926 $78.2 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $3.65 Million - $4.55 Million	-19,973 Reduced 3.89%	493,256 $107 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $32.3 Million - $37.6 Million	-189,782 Reduced 27.0%	513,229 $97.1 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $8.54 Million - $10.5 Million	-53,841 Reduced 7.11%	703,011 $124 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $3.17 Million - $4.04 Million	-24,021 Reduced 3.08%	756,852 $124 Million
Q4 2020 Feb 16, 2021	BUY	$109.38 - $149.19 $85.4 Million - $116 Million	780,873 New	780,873 $109 Million

Others Institutions Holding MEDP

# of Institutions

622

Shares Held

25.1M

Call Options Held

154K

Put Options Held

117K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Medpace Holdings, Inc. Transaction History